Symposium 2007
Symposium 2007 Presentation Summaries
-
Overview of the Metabolic Syndrome
Resistance to the normal physiological actions of insulin, with its many metabolic and health consequences, arises from a complex interplay between genetic predisposition and lifestyle factors, particularly excess caloric intake and reduced levels of physical activity. Approximately 25%...
Continue reading -
Diet and LDL Subclasses
The atherogenic dyslipidemia seen in patients with obesity, diabetes, and the metabolic syndrome includes elevated plasma levels of triglyceride along with reduced high-density lipoprotein (HDL) cholesterol (C). Low-density lipoprotein (LDL) cholesterol levels are not characteristically...
Continue reading -
Diet and Glucose Metabolism
Metabolic syndrome represents a complex interaction between genetic, metabolic, environmental and lifestyle factors, of which diet and physical activity are a key part. Nutrition therapy can play an integral role in the treatment of metabolic syndrome and patient self-management,...
Continue reading -
Abdominal Obesity and the Metabolic Syndrome
This presentation focused on the role of obesity as a key feature of the metabolic syndrome. The World Health Organization, National Cholesterol Education Program, and International Diabetes Federation have all recognized the metabolic syndrome as a highly prevalent risk factor for type 2...
Continue reading -
Blood Pressure and the Metabolic Syndrome
Elevated blood pressure is one of the components of the metabolic syndrome, and the relationship between sodium and blood pressure is well established. It has been suggested that a reduction in sodium intake of ~1.8 grams/day would decrease hypertension prevalence in Canada by over 30%...
Continue reading
Speakers
-
Susan Barr, PhD, RD
Professor of Nutrition, University of British Columbia
-
Ian Janssen, PhD
Assistant Professor, School of Kinesiology and Health Studies and Department of Community Health and Epidemiology, Queen’s University
-
Ronald Krauss, MD
Director, Atherosclerosis Research, Children’s Hospital Oakland Research Institute; Guest Senior Scientist, Department of Genome Sciences, Lawrence Berkeley National Laboratory; Adjunct Professor, Department of Nutritional Sciences, University of California at Berkeley
-
Gary F. Lewis, MD, FRCPC
Professor, Department of Medicine and Physiology, University of Toronto; Head, Division of Endocrinology and Metabolism, University Health Network and Mount Sinai Hospital; Canada Research Chair in Diabetes
